Screening compound: InChI=1S/C17H18ClN3O5S/c1-20-13-8-12(16(26-4)9-14(13)21(2)17(20)22)19-27(23,24)10-5-6-15(25-3)11(18)7-10/h5-9,19H,1-4H3

Screening compound: InChI=1S/C17H18ClN3O5S/c1-20-13-8-12(16(26-4)9-14(13)21(2)17(20)22)19-27(23,24)10-5-6-15(25-3)11(18)7-10/h5-9,19H,1-4H3
Screening compound: InChI=1S/C17H18ClN3O5S/c1-20-13-8-12(16(26-4)9-14(13)21(2)17(20)22)19-27(23,24)10-5-6-15(25-3)11(18)7-10/h5-9,19H,1-4H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C17H18ClN3O5S/c1-20-13-8-12(16(26-4)9-14(13)21(2)17(20)22)19-27(23,24)10-5-6-15(25-3)11(18)7-10/h5-9,19H,1-4H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C301-8058

Molecular Formula

C17H18ClN3O5S (C17 H18 ClN3 O5 S)

Compound Name

3-chloro-4-methoxy-N-(6-methoxy-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)benzene-1-sulfonamide

IUPAC name

3-chloro-4-methoxy-N-(6-methoxy-13-dimethyl-2-oxo-23-dihydro-1H-13-benzodiazol-5-yl)benzene-1-sulfonamide

SMILES

CN(c(c(N1C)c2)cc(NS(c(cc3)cc(Cl)c3OC)(=O)=O)c2OC)C1=O

InChI

InChI=1S/C17H18ClN3O5S/c1-20-13-8-12(16(26-4)9-14(13)21(2)17(20)22)19-27(23,24)10-5-6-15(25-3)11(18)7-10/h5-9,19H,1-4H3

InChI Key

KCFDOCNNTUSKNL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14745219

InChI=1S/C17H18ClN3O5S/c1-20-13-8-12(16(26-4)9-14(13)21(2)17(20)22)19-27(23,24)10-5-6-15(25-3)11(18)7-10/h5-9,19H,1-4H3 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Anticancer Library (62698 compounds)

Antimitotic Tubulin Library (17355 compounds)

Antiviral Library (67538 compounds)

Protein-Protein Interaction Library (218420 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Immune system
Mechanism of action:
  • PPI modulators
  • Receptor's ligands

References: we are preparing a list of scientific research reports with InChI=1S/C17H18ClN3O5S/c1-20-13-8-12(16(26-4)9-14(13)21(2)17(20)22)19-27(23,24)10-5-6-15(25-3)11(18)7-10/h5-9,19H,1-4H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C17H18ClN3O5S/c1-20-13-8-12(16(26-4)9-14(13)21(2)17(20)22)19-27(23,24)10-5-6-15(25-3)11(18)7-10/h5-9,19H,1-4H3?
Check Price and Availability of InChI=1S/C17H18ClN3O5S/c1-20-13-8-12(16(26-4)9-14(13)21(2)17(20)22)19-27(23,24)10-5-6-15(25-3)11(18)7-10/h5-9,19H,1-4H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C17H18ClN3O5S/c1-20-13-8-12(16(26-4)9-14(13)21(2)17(20)22)19-27(23,24)10-5-6-15(25-3)11(18)7-10/h5-9,19H,1-4H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C17H18ClN3O5S/c1-20-13-8-12(16(26-4)9-14(13)21(2)17(20)22)19-27(23,24)10-5-6-15(25-3)11(18)7-10/h5-9,19H,1-4H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C17H18ClN3O5S/c1-20-13-8-12(16(26-4)9-14(13)21(2)17(20)22)19-27(23,24)10-5-6-15(25-3)11(18)7-10/h5-9,19H,1-4H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C17H18ClN3O5S/c1-20-13-8-12(16(26-4)9-14(13)21(2)17(20)22)19-27(23,24)10-5-6-15(25-3)11(18)7-10/h5-9,19H,1-4H3 available by request